Literature DB >> 16153906

Effects of off-pump versus on-pump coronary artery bypass grafting on function and viability of circulating endothelial progenitor cells.

Marc Ruel1, Erik J Suuronen, Jianming Song, Varun Kapila, Derek Gunning, Geeta Waghray, Fraser D Rubens, Thierry G Mesana.   

Abstract

OBJECTIVE: Off-pump coronary artery bypass grafting may result in fewer myocardial and vascular complications than on-pump. Although differences in aortic manipulations likely play a role, the systemic responses of endothelial progenitor cells to both types of operations have not been examined. We sought to examine endothelial progenitor cell characteristics after off-pump versus on-pump coronary artery bypass grafting.
METHODS: Twenty patients undergoing off-pump or on-pump coronary artery bypass grafting were prospectively enrolled and had endothelial progenitor cells isolated and cultured from their peripheral blood before and 24 hours after surgery. Endothelial progenitor cells were identified by fluorescent dual lectin/low-density lipoprotein binding. Their number, phenotype characteristics, proliferation, migratory function, and viability were determined in a blinded fashion.
RESULTS: Patient characteristics and numbers of grafts were equivalent. Endothelial progenitor cells had similar phenotypes between groups before and after surgery. Off-pump and on-pump coronary artery bypass grafting resulted in similar increases in endothelial progenitor cell numbers and showed equivalent proliferation activity. However, endothelial progenitor cell migratory function was higher in off-pump patients (25.3 +/- 5.0 vs 5.0 +/- 1.0 cells per high-powered field for off-pump vs on-pump coronary artery bypass grafting, respectively; P = .04). Postoperative endothelial progenitor cell viability adjusted for preoperative baseline was also higher after off-pump than on-pump coronary artery bypass grafting by 72.4% +/- 14.6% (P = .01). Endothelial progenitor cells of on-pump patients were less viable after surgery than before surgery, whereas the reverse was observed in off-pump patients.
CONCLUSIONS: Both on-pump and off-pump coronary artery bypass grafting elicit mobilization of endothelial progenitor cells into the peripheral blood. On-pump coronary artery bypass grafting, however, impairs the migratory function and viability of these vascular repair cells, which are conversely preserved after off-pump surgery. Further work is necessary to determine whether the function and viability of endothelial progenitor cells correlate with vascular outcomes and whether their therapeutic modulation may one day benefit coronary artery bypass grafting patients.

Entities:  

Mesh:

Year:  2005        PMID: 16153906     DOI: 10.1016/j.jtcvs.2005.01.013

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  8 in total

1.  The effect of encapsulation of cardiac stem cells within matrix-enriched hydrogel capsules on cell survival, post-ischemic cell retention and cardiac function.

Authors:  Audrey E Mayfield; Everad L Tilokee; Nicholas Latham; Brian McNeill; Bu-Khanh Lam; Marc Ruel; Erik J Suuronen; David W Courtman; Duncan J Stewart; Darryl R Davis
Journal:  Biomaterials       Date:  2013-10-04       Impact factor: 12.479

2.  Spliced stromal cell-derived factor-1α analog stimulates endothelial progenitor cell migration and improves cardiac function in a dose-dependent manner after myocardial infarction.

Authors:  William Hiesinger; John R Frederick; Pavan Atluri; Ryan C McCormick; Nicole Marotta; Jeffrey R Muenzer; Y Joseph Woo
Journal:  J Thorac Cardiovasc Surg       Date:  2010-11       Impact factor: 5.209

3.  Mesenchymal Stem Cell-Derived Extracellular Vesicles Induce Regulatory T Cells to Ameliorate Chronic Kidney Injury.

Authors:  Turun Song; Alfonso Eirin; Xiangyang Zhu; Yu Zhao; James D Krier; Hui Tang; Kyra L Jordan; John R Woollard; Timucin Taner; Amir Lerman; Lilach O Lerman
Journal:  Hypertension       Date:  2020-03-30       Impact factor: 10.190

4.  Human blood and cardiac stem cells synergize to enhance cardiac repair when cotransplanted into ischemic myocardium.

Authors:  Nicholas Latham; Bin Ye; Robyn Jackson; Bu-Khanh Lam; Drew Kuraitis; Marc Ruel; Erik J Suuronen; Duncan J Stewart; Darryl R Davis
Journal:  Circulation       Date:  2013-09-10       Impact factor: 29.690

5.  Interleukin-6 Mediates Post-Infarct Repair by Cardiac Explant-Derived Stem Cells.

Authors:  Audrey E Mayfield; Pushpinder Kanda; Alex Nantsios; Sandrine Parent; Seth Mount; Somya Dixit; Bin Ye; Richard Seymour; Duncan J Stewart; Darryl R Davis
Journal:  Theranostics       Date:  2017-10-17       Impact factor: 11.556

6.  Circulating angiogenic cells can be derived from cryopreserved peripheral blood mononuclear cells.

Authors:  Tanja Sofrenovic; Kimberly McEwan; Suzanne Crowe; Jenelle Marier; Robbie Davies; Erik J Suuronen; Drew Kuraitis
Journal:  PLoS One       Date:  2012-10-25       Impact factor: 3.240

7.  The impact of patient co-morbidities on the regenerative capacity of cardiac explant-derived stem cells.

Authors:  Audrey E Mayfield; Megan E Fitzpatrick; Nicholas Latham; Everad L Tilokee; Melanie Villanueva; Seth Mount; Bu-Khanh Lam; Marc Ruel; Duncan J Stewart; Darryl R Davis
Journal:  Stem Cell Res Ther       Date:  2016-05-26       Impact factor: 6.832

8.  Altered kinetics of circulating progenitor cells in cardiopulmonary bypass (CPB) associated vasoplegic patients: A pilot study.

Authors:  Sanhita Nandi; Uma Rani Potunuru; Chandrani Kumari; Abel Arul Nathan; Jayashree Gopal; Gautam I Menon; Rahul Siddharthan; Madhulika Dixit; Paul Ramesh Thangaraj
Journal:  PLoS One       Date:  2020-11-19       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.